- Company Overview for PHARMAXO LIMITED (14808882)
- Filing history for PHARMAXO LIMITED (14808882)
- People for PHARMAXO LIMITED (14808882)
- More for PHARMAXO LIMITED (14808882)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
23 Oct 2024 | AA01 | Current accounting period extended from 31 December 2024 to 30 June 2025 | |
05 Sep 2024 | TM01 | Termination of appointment of Richard John Wastnage as a director on 1 August 2024 | |
12 Aug 2024 | TM01 | Termination of appointment of Christopher Dean Watt as a director on 1 August 2024 | |
12 Aug 2024 | AP01 | Appointment of Mr. Andrew Robinson as a director on 1 August 2024 | |
12 Aug 2024 | AP01 | Appointment of Mr. Ian Stuart Muir as a director on 1 August 2024 | |
12 Aug 2024 | AP01 | Appointment of Mr. David Slade as a director on 1 August 2024 | |
19 Jun 2024 | TM01 | Termination of appointment of Andrew John Alsop as a director on 31 December 2023 | |
05 Jun 2024 | CS01 | Confirmation statement made on 16 April 2024 with no updates | |
01 Aug 2023 | CH01 | Director's details changed for Andrew John Aslop on 17 April 2023 | |
31 May 2023 | AA01 | Current accounting period shortened from 30 April 2024 to 31 December 2023 | |
31 May 2023 | AP01 | Appointment of Mr Richard John Wastnage as a director on 18 May 2023 | |
17 Apr 2023 | NEWINC |
Incorporation
Statement of capital on 2023-04-17
|